228 related articles for article (PubMed ID: 25789595)
1. Prolactin secretion in polycystic ovary syndrome (PCOS).
Szosland K; Pawlowicz P; Lewiński A
Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
[TBL] [Abstract][Full Text] [Related]
3. What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?
Kim SI; Yoon JH; Park DC; Yang SH; Kim YI
Int J Med Sci; 2023; 20(4):463-467. PubMed ID: 37057215
[No Abstract] [Full Text] [Related]
4. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
[TBL] [Abstract][Full Text] [Related]
5. [Effect of hyperprolactinemia upon clinical symptoms of patients with polycystic ovary syndrome].
Wang Y; Hu ZP; Li MZ; Li R; Wang LN; Chen XN; Yang CS; Qiao J
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2599-603. PubMed ID: 20137674
[TBL] [Abstract][Full Text] [Related]
6. Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome.
Escobar-Morreale HF
Fertil Steril; 2004 Dec; 82(6):1697-9. PubMed ID: 15589886
[TBL] [Abstract][Full Text] [Related]
7. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinemia diagnostics--dilemmas over optimal selection of prolactinemia time points.
Szosland K; Stasiak M; Lewiński A
Ann Agric Environ Med; 2015; 22(2):332-7. PubMed ID: 26094534
[TBL] [Abstract][Full Text] [Related]
9. Prolactin secretion in polycystic ovary syndrome: circadian rhythmicity and dynamic aspects.
Ferrari E; Bossolo PA; Foppa S; Dalzano M; Comis S; Morelli MP; Peveri V; Mengozzi A
Gynecol Endocrinol; 1988 Jun; 2(2):101-11. PubMed ID: 3188970
[TBL] [Abstract][Full Text] [Related]
10. The effect of prolactin levels on MPV in women with PCOS.
Yilmaz Ö; Calan M; Kume T; Temur M; Yesil P; Senses MY
Clin Endocrinol (Oxf); 2015 May; 82(5):747-52. PubMed ID: 25359296
[TBL] [Abstract][Full Text] [Related]
11. Etiological diagnosis of hyperprolactinemia.
Cortet-Rudelli C; Sapin R; Bonneville JF; Brue T
Ann Endocrinol (Paris); 2007 Jun; 68(2-3):98-105. PubMed ID: 17524347
[TBL] [Abstract][Full Text] [Related]
12. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study.
Mahboobifard F; Rahmati M; Amiri M; Azizi F; Ramezani Tehrani F
Adv Med Sci; 2022 Mar; 67(1):79-86. PubMed ID: 34998115
[TBL] [Abstract][Full Text] [Related]
13. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia after laparoscopic ovarian drilling: an unknown phenomenon.
Parsanezhad ME; Alborzi S; Zolghadri J; Parsa-Nezhad M; Keshavarzi G; Omrani GR; Schmidt EH
Reprod Biol Endocrinol; 2005 Aug; 3():31. PubMed ID: 16083511
[TBL] [Abstract][Full Text] [Related]
15. Does elevated morning prolactin concentration in children always mean the diagnosis of hyperprolactinemia?
Stawerska R; Smyczyńska J; Hilczer M; Lewiński A
Exp Clin Endocrinol Diabetes; 2015 Jul; 123(7):405-10. PubMed ID: 26069077
[TBL] [Abstract][Full Text] [Related]
16. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
17. [Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?].
Robin G; Catteau-Jonard S; Young J; Dewailly D
Gynecol Obstet Fertil; 2011 Mar; 39(3):141-5. PubMed ID: 21388855
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI
Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
[TBL] [Abstract][Full Text] [Related]
19. Basal and metoclopramide induced prolactin secretion in lean PCOS women.
Mrozinska S; Przywara-Sikora A; Doroszewska K; Gałuszka-Bednarczyk A; Kiałka M; Guzik J; Janeczko M; Marianowski P; Dabrowski FA; Milewicz T
Neuro Endocrinol Lett; 2019 Dec; 40(6):257-262. PubMed ID: 32200584
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Biochemical Characteristics of Polycystic Ovarian Syndrome among Women in Bangladesh.
Islam S; Pathan F; Ahmed T
Mymensingh Med J; 2015 Apr; 24(2):310-8. PubMed ID: 26007259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
